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Abstract
 
Background.
 
Alcohol consumption is associ-
ated with an increased incidence of hypertension and
stroke, but the triggering mechanisms are unclear. In
animals, alcohol causes activation of the sympathetic
nervous system and also stimulates the release of corti-
cotropin-releasing hormone (CRH), which has sympatho-
excitatory effects when administered centrally.
 
Methods.
 
To determine whether alcohol evokes sym-
pathetic activation and whether such activation is attenu-
ated by the inhibition of CRH release, we measured blood
pressure, heart rate, and sympathetic-nerve action poten-
tials (using intraneural microelectrodes) in nine normal
subjects before and during an intravenous infusion of al-
cohol (0.5 g per kilogram of body weight over a period of
45 minutes) and for 75 minutes after the infusion. Each
subject received two infusions, one after the administra-
tion of dexamethasone (2 mg per day) and one after the
administration of a placebo for 48 hours.
 
Results.
 
The infusion of alcohol alone evoked a
marked (P
 

 
0.001) and progressive increase in the mean
(
 

 
SD) rate of sympathetic discharge, from 16
 

 
3 bursts
per minute at base line to 30
 

 
8 bursts per minute at the
end of the two-hour period. This sympathetic activation was
accompanied during the second hour by an increase in
mean arterial pressure of 10
 

 
5 mm Hg (P
 

 
0.001). After
the administration of dexamethasone, the alcohol infusion
had no detectable sympathetic effect. The dexametha-
sone-induced suppression of sympathetic activation was
associated with a decrease in mean arterial pressure of
7
 

 
6 mm Hg (P
 

 
0.001) during the alcohol infusion and with
suppression of the pressor effect during the second hour.
 
Conclusions.
 
Alcohol induces pressor effects by sym-
pathetic activation that appear to be centrally mediated. It
is possible that these alcohol-induced hemodynamic and
sympathetic actions could participate in triggering cardio-
vascular events. (N Engl J Med 1995;332:1733-7.)
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A
 
LCOHOL consumption is a risk factor for stroke
and is associated with a higher-than-expected in-
cidence of hypertension.
 
1-6
 
 The underlying mechanism
relating heavy alcohol consumption to cardiovascular
events is unclear.
 
7,8
 
 One potential candidate is the sym-
pathetic nervous system. The results of plasma cate-
cholamine measurements after the short-term ingestion
of alcohol in humans are conflicting,
 
5,7,8
 
 but direct re-
cordings of sympathetic-nerve activity suggest that
short-term alcohol ingestion in humans and both short-
and long-term administration of ethanol in rats stimu-
late sympathetic-nerve discharge.
 
9-11
 
 Moreover, in rats
the alcohol-induced increases in blood pressure and
sympathetic activity are centrally mediated.
 
12
 
 
Alcohol stimulates the secretion of corticotropin-
releasing hormone (CRH) in rats,
 
13,14
 
 an effect that
could explain why regular alcohol consumption stimu-
lates cortisol secretion.
 
15
 
 In rats, the intracerebroven-
tricular administration of CRH increases blood pres-
sure
 
16
 
 and stimulates sympathetic activity,
 
17
 
 and the
inhibition of CRH release by dexamethasone attenuates
stress-induced sympathetic activation.
 
18
 
 In humans dex-
amethasone, possibly by its inhibitory effect on CRH
release, inhibits insulin-induced sympathetic activa-
tion.
 
19
 
 
We attempted to determine whether the short-term
intravenous administration of alcohol stimulates sym-
pathetic-nerve activity and, if so, whether the adminis-
tration of dexamethasone attenuates this sympathetic
activation in normal humans. We therefore measured
sympathetic-nerve activity and hemodynamic changes
during two infusions of alcohol, one after the adminis-
tration of dexamethasone and the other after the ad-
ministration of placebo. To gain further insight into the
relation between the sympathetic and vascular actions
of alcohol, we tested the effects of an alpha-adrenergic–
receptor blockade on the hemodynamic response to an
alcohol infusion.
 
M
 
ETHODS
 
Subjects
 
We studied nine normal subjects (three women and six men; mean
[
 

 
SD] weight, 67
 

 
10 kg; height, 175
 

 
8 cm; body-mass index,
21.3
 

 
1.7; and age, 27
 

 
5 years). (Body-mass index was calculated as
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the weight in kilograms divided by the square of the height in
meters.) All the subjects were normotensive, were taking no medica-
tions, and had no evidence of metabolic or cardiovascular disease.
Their customary alcohol consumption was less than 50 g per week.
All the studies were performed in the morning after an overnight fast
over a period of one to six weeks. The subjects were asked to abstain
from alcohol, caffeine, and tobacco for at least 24 hours before each
study. The experimental protocol was approved by the Institutional
Review Board on Human Investigation, and all subjects provided
written informed consent.
 
General Procedures
 
The subjects were studied in the supine position. Data on heart
rate (monitored with an electrocardiograph), respiratory excursions
(pneumobelt), blood pressure (Finapres blood-pressure monitor
[Ohmeda, Englewood, Colo.]),
 
20
 
 blood flow in the calf (venous-occlu-
sion plethysmography),
 
20
 
 and sympathetic-nerve activity in efferent
nerves were recorded continuously on an electrostatic recorder and a
tape recorder (R71, TEAC, Tokyo, Japan). Respiratory excursions
were monitored to detect the inadvertent performance of a Valsalva
maneuver or prolonged expiration, since these respiratory maneuvers
can stimulate sympathetic outflow.
 
20
 
 Intravenous catheters were in-
serted in a right and a left antecubital vein, one for the alcohol infu-
sion and the other for blood sampling.
 
Recordings of Sympathetic-Nerve Activity
 
Postganglionic sympathetic-nerve activity was recorded with uni-
polar tungsten microelectrodes inserted selectively into muscle–
nerve fasciculi of the peroneal nerve posterior to the fibular head by
the microneurographic technique of Vallbo et al.
 
21
 
 The neural signals
were amplified 20,000 to 50,000 times, filtered (band width, 700 to
2000 Hz), rectified, and integrated (time constant, 0.1 second) to ob-
tain a display of the mean voltage of sympathetic activity. A record-
ing of sympathetic activity was considered acceptable when it re-
vealed spontaneous, pulse-synchronous bursts of neural activity, with
the largest bursts showing a minimal signal-to-noise ratio of 3:1. In
each study, we documented that we were recording the sympathetic
outflow to skeletal muscle by demonstrating that the neural activity
did not respond to arousal stimuli (a loud noise) or a pinch of the
skin but showed a characteristically biphasic response to the Valsalva
maneuver.
 
22
 
 
For analysis, printed filtered and mean-voltage neurograms were
inspected visually to identify bursts of sympathetic-nerve discharge.
The recordings were all analyzed by the same observer, who was un-
aware of whether the subject had received dexamethasone or placebo
before the study. The intraobserver and interobserver coefficients of
variation of the mean in identifying bursts were less than 6 percent
and less than 9 percent, respectively.
 
20
 
 Nerve traffic was expressed
both as the number of bursts per minute, an index of the frequency
of the activity, and as the number of bursts per minute times the
mean amplitude of the bursts, an index of integrated (total) activity.
For quantitative analysis, the results were normalized by transcribing
the nerve recordings from FM tape to hard copy in such a way that
mean burst amplitudes were comparable in all subjects.
 
Measurement of Blood Flow in Muscle
 
While recording the sympathetic-nerve outflow to the calf muscles
in one leg, we simultaneously measured blood flow in the calf of the
contralateral leg by venous-occlusion plethysmography, using mercu-
ry-in-Silastic strain gauges.
 
20
 
 The calf was elevated 10 to 15 cm above
the level of the right atrium to collapse the veins. The circulation to
the foot was arrested by inflating a cuff around the ankle during each
determination of blood flow; determinations were made at 15-second
intervals over a 5-minute period.
 
Analytic Methods
 
Plasma alcohol concentrations were measured enzymatically (Al-
cool PAP, Biomérieux, Mercy l’Etoile, France). Plasma norepineph-
rine was measured by high-performance liquid chromatography,
 
20
 
and plasma insulin and cortisol by radioimmunoassay (Gamma-BCT
Cortisol IDS, Boldon, United Kingdom). All samples from the same
subject were analyzed at the same time in each assay.
 
Experimental Protocols
 
Alcohol Infusion after the Administration of Dexamethasone 
and Placebo
 
All nine subjects received in randomized, double-blind sequence
either dexamethasone (2 mg per day in four divided doses) or identi-
cal placebo pills for 48 hours before each of two alcohol infusions.
The last dose of dexamethasone or placebo was administered on the
morning of the test. After base-line measurements for 30 minutes, al-
cohol (ethanol, 0.5 g per kilogram of body weight) diluted in normal
saline to make a 10 percent solution was infused over a 45-minute pe-
riod. Sympathetic-nerve activity and hemodynamic measurements
were recorded for 5 minutes of each 15-minute period during the 30-
minute base-line period, the 45 minutes of the alcohol infusion, and
the 75 minutes after the infusion. Immediately thereafter, in six sub-
jects, we used baroreceptor deactivation evoked by the Valsalva
maneuver
 
19
 
 and stimulation of cutaneous afferent nerves by a two-
minute immersion of the hand in ice water
 
19
 
 (the cold pressor test)
to examine the effects of dexamethasone on the responses to stimuli
of sympathetic discharge other than alcohol. Blood samples were col-
lected at base line and 15, 30, 45, 60, 90, and 120 minutes after the
start of the alcohol infusion for analysis of plasma concentrations of
alcohol and hormones.
 
Effects of Alpha-Adrenergic Blockade (Phentolamine Infusion) 
on Hemodynamic Responses to Alcohol Infusion
 
We assessed the effects of alpha-adrenergic blockade on hemody-
namic responses to alcohol infusion. The purpose of this part of the
study was to determine whether the dexamethasone-induced attenu-
ation of the alcohol-induced pressor response was causally related to
the attenuation of alcohol-induced sympathetic activation. Five of the
nine subjects participated in this test. After base-line measurements
for 30 minutes, phentolamine was administered as a primed infusion
(70 
 
m
 
g per kilogram given over a 5-minute period) and then as a con-
tinuous infusion (7 
 
m
 
g per kilogram per minute) for 55 minutes, after
which alcohol (at the dose used in the first part of the study) and
phentolamine (7 
 
m
 
g per kilogram per minute) were infused together
for 45 minutes. After the cessation of the alcohol infusion, phentola-
mine was infused for another 75 minutes at the same dose. Hemody-
namic measurements were recorded for 5 minutes during each 15-
minute period of the 30-minute base-line period and of the 3 hours
of the phentolamine infusion.
The efficacy of the alpha-adrenergic blockade was then assessed by
examining the pressor response and the vascular-resistance response
in the calf evoked by immersing the subject’s hand in ice water for
two minutes. The mean (
 

 
SD) arterial pressure increased by 25
 

 
9
mm Hg and the vascular resistance in the calf increased by 17
 

 
11
units before the phentolamine infusion, but the mean arterial pres-
sure increased by only 13
 

 
4 mm Hg and the vascular resistance de-
creased by 5
 

 
14 units during the infusion.
 
Effects of a Bolus Dose of Dexamethasone on Sympathetic 
Activity and Arterial Pressure
 
We also determined the effects of the administration of a bolus
dose of dexamethasone alone (in the absence of alcohol) on sympa-
thetic-nerve traffic and arterial pressure. Five other normal subjects
(four women and one man; weight, 62
 

 
8 kg; height, 169
 

 
7 cm;
body-mass index, 22.0
 

 
1.6; and age, 27
 

 
6 years) participated. After
base-line measurements for 30 minutes, 2 mg of dexamethasone was
administered intravenously as a bolus dose, followed by an infusion
of saline at the same rate and for the same duration as the infusion
of alcohol in the first part of the study. Nerve traffic and arterial
pressure were measured for two hours after the dexamethasone ad-
ministration.
 
Statistical Analysis
 
Mean arterial pressure was calculated as diastolic blood pressure
plus one third of the pulse pressure. Vascular resistance in the calf
The New England Journal of Medicine 
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was determined as the mean arterial pressure
in millimeters of mercury divided by the
blood flow in milliliters per minute per 100
milliliters of tissue; it was expressed in units.
The measurements of sympathetic-nerve
activity, blood flow in the calf, blood pres-
sure, and heart rate that were collected for
5 of every 15 minutes were averaged to a sin-
gle value.
The statistical analysis was performed
with an analysis of variance with repeated
measures and paired two-tailed t-tests. Un-
less otherwise indicated, data are given as
means 
 

 
SD. A P value of less than 0.05 was
considered to indicate statistical significance.
 
R
 
ESULTS
 
Responses to the Alcohol Infusion after 
Dexamethasone and Placebo
 
The base-line values for sympa-
thetic-nerve discharge, plasma nor-
epinephrine concentration, vascular
resistance in the calf, and blood
pressure were not altered by the ad-
ministration of dexamethasone. Compliance with the
administration of dexamethasone was documented by
the presence of plasma cortisol concentrations markedly
lower than those measured after the administration of
placebo (2.1
 

 
2.7 vs. 12.3
 

 
5.4 
 
m
 
g per deciliter [57
 

 
74
vs. 339
 

 
149 nmol per liter], P
 

 
0.001). The increases in
plasma alcohol concentrations were similar under both
experimental conditions (Table 1). Base-line plasma in-
sulin concentrations were higher (P
 

 
0.004) after dexa-
methasone than after placebo. During the alcohol infu-
sion, the mean plasma insulin concentration increased
slightly, albeit significantly (P
 

 
0.01), both after place-
bo (from 6.6
 

 
2.9 to 8.2
 

 
2.4 
 
m
 
U per milliliter [40
 

 
17
to 49
 

 
14 pmol per liter] at 120 minutes) and after dex-
amethasone (from 11.2
 

 
4.1 to 13.5
 

 
6.6 
 
m
 
U per milli-
liter [67
 

 
25 to 81
 

 
40 pmol per liter]).
After the administration of placebo, the alcohol
infusion evoked marked, roughly linear increases in
sympathetic-nerve activity (Fig. 1 and 2 and Table 1);
at the end of the two-hour study period, the frequency
of sympathetic-nerve bursts had increased by 97
 

 
54
percent and total activity by 127
 

 
84 percent
(P
 

 
0.001). During the second hour, this progressive
stimulation of sympathetic-nerve discharge was ac-
companied by an increase of 10
 

 
5 mm Hg (P
 

 
0.001)
in mean arterial pressure (Fig. 2 and Table 1). The
alcohol-induced increases in sympathetic-nerve dis-
charge in skeletal muscle were reflected by significant
increases in plasma norepinephrine concentrations. In
contrast, the infusion of alcohol after the administra-
tion of dexamethasone had no detectable effect on
sympathetic-nerve discharge (or on plasma norepi-
nephrine concentrations). The lack of sympathetic
activation was associated with a decrease of 7
 

 
6
 
*Values are means 
 

 
SD for nine subjects except in the case of plasma norepinephrine (n
 

 
6). Alcohol (0.5 g per kilogram) was infused for 45 minutes. The P values are for the comparisons
with the base-line values. To convert values for plasma norepinephrine to nanomoles per liter, multiply by 0.0059; to convert values for plasma alcohol to millimoles per liter, multiply by 0.22. NS
denotes not significant.
†P
 

 
0.04 for the comparison with alcohol infusion after placebo.
‡P
 

 
0.003 for the comparison with alcohol infusion after placebo.
§Units of sympathetic-nerve activity are calculated as the number of bursts per minute times the mean amplitude of the bursts.
¶P
 

 
0.01 for the comparison with alcohol infusion after placebo. **P
 

 
0.002 for the comparison with alcohol infusion after placebo.
 

 
P
 

 
0.007 for the comparison with alcohol infusion after placebo. ††P
 

 
0.02 for the comparison with alcohol infusion after placebo.
 
Table 1. Responses to Alcohol Infusions Given after the Administration of Placebo or Dexamethasone for 48 Hours in
Normal Subjects.
 
*
 
V
 
ARIABLE
 
A
 
LCOHOL
 
 I
 
NFUSION
 
 
 
AFTER
 
 P
 
LACEBO
 
A
 
LCOHOL
 
 I
 
NFUSION
 
 
 
AFTER
 
 D
 
EXAMETHASONE
BASE
 
 
 
LINE
AFTER
 
60 
 
MIN
 
P 
 
VALUE
AFTER
 
120 
 
MIN
 
P 
 
VALUE BASE
 
 
 
LINE
AFTER
 
60 
 
MIN
 
P 
 
VALUE
AFTER
 
120 
 
MIN
 
P 
 
VALUE
 
Sympathetic-nerve activity
Bursts/min
Units§
16
 

 
3
234
 

 
40
22
 

 
5
379
 

 
100
 

 
0.001
0.003
30
 

 
8
520
 

 
187
 

 
0.001
 
0.001
165
24667
175†
25266¶
NS
NS
175‡
27586
NS
NS
Mean arterial pressure (mm Hg) 905 927 NS 1008 0.001 905 858** 0.003 897‡ NS
Heart rate (beats/min) 657 728 0.005 739 0.001 626 705 0.001 727 0.001
Vascular resistance in the calf (units) 5516 5613 NS 5517 NS 5616 5115 0.004 4814 0.001
Plasma norepinephrine (pg/ml) 18242 23179 0.007 23777 0.003 15329 16442 NS 16752†† NS
Plasma alcohol (mg/dl) 00 638 0.001 457 0.001 00 626 0.001 425 0.001
Figure 1. Representative Recordings of Sympathetic-Nerve Activity in a Normal Sub-
Dexamethasone
Placebo
Base line Alcohol infusion
15 sec
ject before and 120 Minutes after the Start of the Alcohol Infusion.
The infusions were given after the administration of placebo and dexamethasone.
Each peak represents a spontaneous burst of sympathetic-nerve discharge.
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mm Hg (P0.001) in mean arterial pressure during
the infusion of alcohol and with the absence of a pres-
sor effect during the second hour (Fig. 1 and 2 and
Table 1).
In contrast to its effects on alcohol-induced sympa-
thetic activation, dexamethasone did not alter sympa-
thetic responses to the Valsalva maneuver or to immer-
sion of the hand in ice water. The peak sympathetic
responses during a Valsalva maneuver were 6911
bursts per minute after placebo and 627 after dexa-
methasone. During immersion of the hand in ice water,
the peak sympathetic responses were 377 and 434
bursts per minute, respectively.
Cardiovascular Responses to the Alcohol Infusion during 
Alpha-Adrenergic Blockade
During the infusions of alcohol and phentolamine, the
blood-pressure response (Fig. 3) and vascular-resist-
ance response in the calf (decreasing from 5424 units
at base line to 4126 units at 120 minutes, P0.001)
mimicked those observed during the alcohol infusion af-
ter dexamethasone. In contrast, the peak response of
the heart rate was more pronounced after phentolamine
than after dexamethasone (8820 vs. 697 beats per
minute, P0.04).
Cardiovascular and Sympathetic Responses to a Bolus 
Dose of Dexamethasone
Dexamethasone had no detectable effect on arterial
pressure, heart rate, vascular resistance in the calf, or
sympathetic-nerve discharge. The mean values at base
line and two hours after dexamethasone administration
were as follows: mean arterial pressure, 948 and
969 mm Hg; heart rate, 618 and 639 beats per
minute; vascular resistance in the calf, 5716 and
5914 units; and sympathetic-burst frequency, 206
and 216 bursts per minute.
DISCUSSION
We found that an infusion of alcohol roughly dou-
bled the rate of sympathetic-nerve discharge and in-
creased arterial pressure, and that these sympatho-
excitatory and pressor effects were blocked by the
administration of dexamethasone. These findings indi-
cate that alcohol exerts a pressor effect in humans by
causing sympathetic activation, an effect that is proba-
bly centrally mediated. The results of previous studies
of the effects of alcohol on sympathetic activity were
Figure 2. Mean (SE) Effects of an Infusion of Alcohol in Nine
Normal Subjects after the Administration of Placebo () or Dex-
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amethasone (). 
The alcohol-induced sympathetic and pressor effects were abol-
ished after the administration of dexamethasone (P0.001 for
the comparison between placebo and dexamethasone). To con-
vert values for plasma alcohol to millimoles per liter,
multiply by 0.22.
Figure 3. Mean (SE) Changes in Arterial Pressure in Five Nor-
mal Subjects in Response to an Alcohol Infusion during the Ad-
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ministration of Placebo (), Dexamethasone (), or
Phentolamine ().
Alpha-adrenergic blockade and the suppression of alcohol-
induced sympathetic activation by dexamethasone had similar
effects on the blood-pressure responses evoked by an infusion
of alcohol (P0.001 for the comparison of placebo with either
dexamethasone or phentolamine).
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conflicting.5,7,8 Moreover, in the studies in which alco-
hol was administered orally, the relative sympathoexci-
tatory contributions of alcohol itself, alcohol-induced
gastric irritation and distention, and stimulation of in-
sulin release could not be distinguished.23 Intravenous
infusion of alcohol combined with direct measurement
of sympathetic-nerve discharge allowed us to eliminate
these confounding issues. Our results indicate that al-
cohol increases postganglionic sympathetic-nerve dis-
charge and are consistent with the preliminary findings
made after the oral administration of alcohol.9 
Our results provide some mechanistic insight into al-
cohol-induced sympathetic activation. In rats, alcohol
stimulates CRH release13,14; both alcohol12 and CRH18
exert sympathoexcitatory and pressor effects when ad-
ministered centrally; and dexamethasone, presumably
by inhibiting CRH release, attenuates stress-induced
sympathetic activation.18 In this study of humans, dex-
amethasone impaired the ability of alcohol to stimulate
the discharge of sympathetic nerves. This response was
not related to a nonspecific impairment of sympathetic
responsiveness, since dexamethasone had no effect on
either the base-line rate of sympathetic-nerve firing or
responses to stimuli other than alcohol. Taken together,
the results in animals and humans are consistent with
the concept that sympathetic activation is related to
a central neural action of alcohol, possibly involving
CRH release.
The suppression of sympathetic activation markedly
altered the cardiovascular responses to an infusion of al-
cohol. After the administration of placebo, alcohol in-
creased sympathetic-nerve activity, did not affect vascu-
lar resistance in a limb, and increased the heart rate
and mean arterial pressure. After the administration of
dexamethasone, sympathetic activity did not increase,
and alcohol caused vasodilation in the calf and a de-
crease in mean arterial pressure. These results are
strengthened by the studies with phentolamine, which
demonstrated the importance of sympathetic activation
in mediating alcohol-induced pressor responses, and
they have implications for the effects of alcohol on blood
pressure in patients who either have autonomic dysfunc-
tion or are taking alpha-adrenergic–blocker drugs.
Increases in the heart rate during the administration
of alcohol are thought to be mediated sympathetically
because they are abolished by propranolol.24 In our
study, increases in the heart rate after dexamethasone
were similar to those after placebo, not greater, even
though suppression of the pressor response would be
expected to result in the removal of baroreflex restraint
on heart-rate responses (as evidenced by the greater re-
sponse in the heart rate during the infusion of alcohol
in the phentolamine studies). Therefore, it appears that
dexamethasone also attenuated alcohol-induced stimu-
lation of sympathetic outflow to the heart.
Alcohol consumption is associated with an increased
incidence of hypertension4-6 and stroke.1-3 Although
many factors have been implicated in the pathogenesis
of alcohol-induced cardiovascular complications,1,25
sympathetic activation could conceivably trigger acute
events by promoting short-term increases in blood pres-
sure and platelet aggregation.26,27 Whether sympathetic
activation also contributes to long-term elevation of ar-
terial pressure in persons who drink alcohol every day
needs further investigation, but results from studies of
rats suggest that this could be the case.11 
We are indebted to Drs. Laurent Vollenweider and Reza Owlya for
assistance with some of these studies.
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